OMB Control No. 0910-0497 Expiration date: 10/31/2020
APPENDIX A: POTENTIAL STAKEHOLDERS TO CONTACT REGARDING PARTICIPATION FROM MEMBERS OF THEIR ORGANIZATIONS (LIST MAY BE MODIFIED)
Name |
Title |
Organization |
|
Large Distributed Healthcare Data Networks |
|
|
|
Jeffrey Brown, Ph.D. |
Director of Scientific Operations, Associate Professor, Department of Population Medicine, Harvard Medical School |
PCORnet, FDA’s Sentinel Program |
|
Richard Platt, M.D., M.Sc. |
Principal Investigator, Chair of Department of Population Medicine, Harvard Medical School |
PCORnet, FDA’s Sentinel Program |
|
Payers, Healthcare Delivery Systems |
|
|
|
Sarah Priddy Alwardt, Ph.D. |
Vice President Health Informatics and HEOR |
McKesson Specialty Health |
|
Troyen Brennan, M.D. |
Executive Vice President and Chief Medical Officer |
CVS Health |
|
Páll Jónsson, Ph.D., M.Res. |
Associate Director Research and Development |
NICE |
|
Will Shrank, M.D. |
Chief Medical Officer |
UPMC |
|
Sarah Emond MPP |
Executive Vice President and Chief Operating Officer |
ICER |
|
Wim Goettsch PhD |
HTA-advisor |
Dutch National Healthcare Institute |
|
Regulators |
|
|
|
Peter Arlett, B.Sc., M.B.B.S., M.R.C.P., F.F.P.M. |
Head of Pharmacovigilance and Epidemiology Department |
European Medicines Agency (EMA) |
|
Hans-Georg Eichler, M.D., M.Sc. |
Senior Medical Officer |
European Medicines Agency (EMA) |
|
Yoshiaki Uyama, Ph.D. |
Director, Office of Medical Informatics and Epidemiology |
Pharmaceuticals and Medical Devices Agency (PMDA), Japan |
|
David Martin, M.D., M.P.H. |
Liaison to the Reagan Udall Foundation IMEDS Program at U.S. FDA Center for Drug Evaluation and Research (CDER) |
Food and Drug Administration (FDA)
|
|
Michael Nguyen, M.D. |
FDA Sentinel Liaison, CDER |
Food and Drug Administration (FDA) |
|
Richard Swain, PhD |
Acting Team Leader, Office of Surveillance and epidemiology, CDER |
Food and Drug Administration (FDA) |
|
Christian Hampp, PhD |
Master Reviewer, Office of Surveillance and epidemiology, CDER |
Food and Drug Administration (FDA) |
|
Efe Eworuke, PhD |
Team Leader, Office of Surveillance and epidemiology, CDER |
Food and Drug Administration (FDA) |
|
Clara Kim, PhD |
Team Leader, Office of Translational Sciences, CDER |
Food and Drug Administration (FDA) |
|
Elande Baro, PhD |
Statistical Reviewer, Office of Translational Science, CDER |
Food and Drug Administration (FDA) |
|
Stephanie Krauss, JD MPH |
Regulatory Counsel, Office of Regulatory Policy, CDER |
Food and Drug Administration (FDA) |
|
Open Science |
|
|
|
John Ioannidis, M.D., D.Sc. |
Co-Director, Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine |
Meta-Research Innovation Center at Stanford |
|
Brian Nosek, Ph.D. |
Executive Director, Professor of Psychology, University of Virginia |
Center for Open Science |
|
Journal Editors |
|
|
|
Sean Hennessy, Pharm.D., Ph.D. |
Professor of Epidemiology and of Systems Pharmacology and Translational Therapeutics |
University of Pennsylvania Perelman School of Medicine |
|
Laura Happe |
Editor in Chief of Journal of Managed Care and Specialty Pharmacy |
Journal of Managed Care and Specialty Pharmacy |
|
Christine Laine, M.D., M.P.H., F.A.C.P. |
Editor in Chief, Associate Professor, Jefferson Medical College |
Annals of Internal Medicine |
|
Elizabeth Loder, M.D., M.P.H. |
Head of Research, BMJ, Professor of Neurology, Harvard Medical School |
BMJ |
|
Henrik Toft Sørensen, M.D., Ph.D. |
Editor in Chief |
Clinical Epidemiology |
|
Peter Tugwell, M.Sc., M.D., F.R.C.P.C. |
North American Editor, Professor of Medicine and Epidemiology & Community Medicine at the University of Ottawa |
Journal of Clinical Epidemiology |
|
Wolfgang Winkelmayer, M.D., M.P.H., Sc.D., F.A.S.N. |
Associate Editor, Professor of Medicine and Chief, Section of Nephrology, Baylor College of Medicine |
Journal of the American Medical Association (JAMA) |
|
Professional Society/Guidelines |
|
|
|
Jesper Hallas, M.D., Ph.D. |
President |
ISPE |
|
Sinead Langan PhD |
Wellcome Senior Clinical Fellow and Professor |
RECORD guidelines |
|
Dick Willke, Ph.D. |
Chief Scientific Officer |
ISPOR |
|
International Network of Academics |
|
|
|
K. Arnold Chan, M.D., Sc.D. |
Director, Health Data Research Center |
National Taiwan University |
|
Nam-Kyong Choi, B. Pharm., Ph.D. |
Assistant Professor, Korea Institute of Drug Safety & Risk Management (KIDS) Advisor, Asian Pharmacoepidemiology Network (AsPEN) Chair-Elect |
Ewha Womans University |
|
Frank de Vries, Pharm.D., Ph.D. |
Head of Research |
Department of Clinical Pharmacy, Maastricht UMC+ The Netherlands |
|
Contract Research Organization |
|
|
|
Alison Bourke, M.Sc., F.R.Pharm.S. |
Scientific Director, Real World Insights, QuintilesIMS |
QuintilesIMS |
|
John Seeger, Pharm.D., Dr.P.H. |
Chief Scientific Officer |
Optum Epidemiology |
Name |
Title |
Organization |
Pharmaceutical Industry |
|
|
Dorothee Bartels, M.Sc., Ph.D. |
Head of Global Epidemiology |
Boehringer Ingelheim GmbH |
Andrew Bate, Ph.D. |
Senior Director, Analytics Team Lead in Epidemiology |
Pfizer |
Brian Bradbury, D.Sc. |
Executive Director, Center for Observational Research |
Amgen |
Javier Jimenez, M.D., M.P.H. |
VP, Global Head RWE and Clinical Outcomes |
Sanofi |
Kris Kahler, Ph.D. |
Executive Director and the Global Head of Outcomes Evidence & Analytics |
Novartis |
Joanne Waldstreicher, M.D. |
Chief Medical Officer |
Johnson & Johnson |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Opper, Gretchen |
File Modified | 0000-00-00 |
File Created | 2021-01-15 |